CRISPR Therapeutics to Present at Upcoming Investor Conferences

Date : 11/27/2019 @ 12:00PM
Source : GlobeNewswire Inc.
Stock : CRISPR Therapeutics AG (CRSP)
Quote : 58.33  -1.3 (-2.18%) @ 11:17PM
CRISPR Therapeutics share price Chart
After Hours
Last Trade
Last $ 58.30 ▼ -0.03 (-0.05%)

CRISPR Therapeutics to Present at Upcoming Investor Conferences

Historical Stock Chart

2 Months : From Nov 2019 to Jan 2020

Click Here for more CRISPR Therapeutics Charts.

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to make the following presentations in December:

Evercore ISI 2nd Annual HealthCONx Date: Wednesday, December 4, 2019 Presentation: 11:00 a.m. ET Location: Boston, MA

Piper Jaffray 31st Annual Healthcare Conference Date: Thursday, December 5, 2019 Presentation: 2:00 p.m. ET Location: New York, NY

A live webcast of the events will be available on the "Events & Presentations" page in the Investors section of the Company's website at A replay of the webcast will be archived on the Company's website for 30 days following the presentation.

About CRISPR Therapeutics

CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a revolutionary gene editing technology that allows for precise, directed changes to genomic DNA. CRISPR Therapeutics has established a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine and rare diseases. To accelerate and expand its efforts, CRISPR Therapeutics has established strategic collaborations with leading companies including Bayer AG, Vertex Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland, with its wholly-owned U.S. subsidiary, CRISPR Therapeutics, Inc., and R&D operations based in Cambridge, Massachusetts, and business offices in London, United Kingdom. For more information, please visit

Investor Contact:Susan

Media Contact:Jennifer PaganelliWCG on behalf of

Latest CRSP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20200119 02:42:55